Creative Planning Lannett CO Inc Transaction History

Creative Planning

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.45 - $0.86 $9,450 - $18,060	21,000 Added 42.0%	71,000 $36,000
Q2 2022 Aug 15, 2022	BUY	$0.47 - $0.87 $4,700 - $8,700	10,000 Added 25.0%	50,000 $29,000
Q1 2022 May 16, 2022	BUY	$0.75 - $1.77 $7,500 - $17,700	10,000 Added 33.33%	40,000 $32,000
Q4 2021 Feb 11, 2022	BUY	$1.56 - $2.93 $31,200 - $58,600	20,000 Added 200.0%	30,000 $49,000
Q3 2021 Nov 10, 2021	BUY	$2.91 - $4.83 $29,100 - $48,300	10,000 New	10,000 $30,000

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.